Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Wei Deng's publication output changed over time?
ScholarIQpublication output · 2011–2024
Output grew0% over the shown period — from 1 works in 2011 to 1 in 2024.
1
1
2
1
2
2
1
1
20112015201720182019202020212024
What are the most-cited papers on Wei Deng?
ScholarIQmost cited works
SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis
Ruben A. Mesa, Jean‐Jacques Kiladjian, John Catalano, Timothy Devos, Miklós Egyed, Andrzei Hellmann, Donal P. McLornan, Kazuya Shimoda, Elliott F. Winton, Wei Deng, Ronald L. Dubowy, Julia D. Maltzman, Francisco Cervantes, Jason Gotlib
Journal of Clinical Oncology. 2017375 CitationsOPEN ACCESS
Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)
Alessandro D. Santin, Wei Deng, Michael Frumovitz, Natália Buza, Stefania Bellone, Warner K. Huh, Samir N. Khleif, Heather A. Lankes, Elena Ratner, Roisin E. O’Cearbhaill, Amir A. Jazaeri, Michael J. Birrer
Gynecologic Oncology. 2020155 CitationsOPEN ACCESS
The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy
Wei Deng, Xu Cai, Amy Liu, Peter S.N. van Rossum, Weiye Deng, Zhongxing Liao, Albert C. Koong, Radhe Mohan, Steven H. Lin
Radiotherapy and Oncology. 201986 Citations
Long‐term safety and efficacy of deferasirox (Exjade<sup>®</sup>) for up to 5 years in transfusional iron‐overloaded patients with sickle cell disease
Elliott Vichinsky, Françoise Bernaudin, Gian Luca Forni, Renée V. Gardner, Kathryn Hassell, Matthew M. Heeney, Baba Inusa, Abdullah Kutlar, Peter A. Lane, Liesl Mathias, John B. Porter, Cameron K. Tebbi, Felicia Wilson, Louis Griffel, Wei Deng, Vanessa Giannone, Thomas D. Coates
S153015021. 201178 CitationsOPEN ACCESS
Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future
Wenxi Fang, Saiyang Xie, Wei Deng
S31257671. 202472 CitationsOPEN ACCESS
Related on ScholarIQ
Guangzhou University of Chinese Medicine
Institution
SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis
Paper
Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)
Paper
The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy
Paper
Long‐term safety and efficacy of deferasirox (Exjade<sup>®</sup>) for up to 5 years in transfusional iron‐overloaded patients with sickle cell disease
Paper
Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future
Paper